Related Experiment Video
Updated: Nov 17, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Hormone Receptor-Positive, HER2-Negative Breast Cancer: Recent Advances and Best Practices
Lee Schwartzberg1, Heather Greene1
1West Cancer Center & Research Institute, Memphis, Tennessee.
Abstract:
Lee Schwartzberg, MD, FACP, and Heather Greene, MSN, FNP, AOCNP®, reviewed optimal therapy for patients with hormone receptor-positive, HER2-negative breast cancer, as well as the management of adverse events associated with treatment.
More Related Videos
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
08:28Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025